Subscribe
Sign In
Tag: CBT > Controlled Substances Act
Top Stories
Cannabis Rescheduling Won’t Solve Industry Banking Problems, Legal Risks
Bank Secrecy Act obligations and federal anti-money laundering laws would still apply to cannabis under a Schedule III listing, legal expert says.
October 23, 2024
Top Stories
2 US House Democrats Nudge DEA to ‘Swiftly’ Reschedule Cannabis
Reps. Jerry Nadler and Frank Pallone Jr., both ranking members, wrote a letter to the attorney general and DEA administrator.
October 2, 2024
California
Treez Files Summary Judgement in Lawsuit Against Feds Over Cannabis-Related Visa Denial
The federal government claims Treez must show its software developer from India ‘does not aid and abet activities that violate the CSA.’
September 19, 2024
Cannabis Advertising
The Complex Impact of Rescheduling Cannabis on Advertising
The penalties for advertising Schedule I drugs don’t apply to Schedule III drugs, but cannabis businesses could be left in a precarious position.
September 17, 2024
Industry Headlines
MMJ BioPharma Suing DEA Over Cannabis Reform, Medical Research
The biopharmaceutical company filed a lawsuit, citing ‘unjustified’ delays in processing an application for medical research.
September 11, 2024
Banking Bill Cannabis Industry
Trump Signals Support for Federal Cannabis Rescheduling, Banking Reform
The GOP presidential candidate said he will focus on unlocking the ‘medical uses of marijuana to a Schedule 3 drug’ if elected in November.
September 9, 2024
2018 Farm Bill Status
4th Circuit Court Rules THC-O Meets Legal Definition of Hemp, Deviating From DEA
The federal court’s interpretation of the 2018 Farm Bill contradicts the Drug Enforcement Administration’s position that THC-O is illegal.
September 9, 2024
Cannabis Rescheduling
Cannabis Rescheduling No Longer on Fast Track; Hearing Scheduled For December
The DEA will not issue a final rule before the November election now that Administrator Anne Milgram granted an administrative law judge hearing.
August 27, 2024
Massachusetts
Judge Dismisses Lawsuit Challenging CSA’s Constitutionality, but Says Cannabis’s Regulation Under CSA Should Be Reexamined
The motion to dismiss a high-profile lawsuit challenging the federal government’s authority to enforce the Controlled Substances Act against state-legal, intrastate cannabis businesses was granted, but the suit ‘alleged persuasive reasons for a reexamination’ of how the CSA regulates cannabis.
July 2, 2024
Massachusetts
Will a Lawsuit Challenging CSA’s Constitutionality Move Forward?
Oral arguments were heard to determine the merits of a lawsuit challenging the federal government’s authority to enforce the Controlled Substances Act against state-legal, intrastate cannabis businesses.
May 22, 2024
Advocacy for Cannabis Legalization
Senate Democrats Introduce Bill to Federally Legalize Cannabis
The Cannabis Administration and Opportunity Act aims to deschedule marijuana by removing it from the Controlled Substances Act.
May 1, 2024
Cannabis Rescheduling
DEA’s 5-Factor Test Makes Rescheduling Cannabis Impossible
After HHS used its own two-part test to determine the plant’s ‘currently accepted medical use,’ rescheduling opponents urge DEA to keep its five-part test.
March 19, 2024
Page 1 of 5
Next Page